Progression-Free Survival (PFS) by Blinded Independent Central Review (BICR) and Updated Overall Survival (OS) of Sunitinib versus Placebo for Patients with Progressive, Unresectable, Well Differentiated Pancreatic Neuroendocrine Tumor (NET) Meeting Abstract

Industry Collaboration International Collaboration

author list

  • Vinik, Aaron, Van Cutsem, Eric, Niccoli, Patricia, Raoul, Jean-Luc, Bang, Yung-Jue, Borbath, Ivan, Lombard-Bohas, Catherine, Valle, Juan W., Metrakos, Peter, Smith, Denis, Chen, Jen-Shi, Hoersch, Dieter, Castellano, Daniel E., Kennecke, Hagen F., Picus, Joel, Van Hazel, Guy, Patyna, Shem, Lu, Dongrui Ray, Chao, Richard C., Raymond, Eric


publication date

  • March 1, 2012


published in


start page

  • 350

end page

  • 350


  • 41


  • 2